Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
6. LITERATURVERZEICHNIS
1. Consensus development conference: diagnosis, prophylaxis, and treatment of
osteoporosis. Am J Med. 1993;94:646-50.
2. Alnaes R, Torgersen S. Personality and personality disorders predict
development and relapses of major depression. Acta Psychiatr Scand. 1997;95:336-42.
3. Alpert JE, Fava M, Uebelacker LA, et al. Patterns of axis I comorbidity in earlyonset
versus late-onset major depressive disorder. Biol Psychiatry. 1999;46:202-11.
4. Angst J. Comorbidity of mood disorders: a longitudinal prospective study. Br J
Psychiatry Suppl. 1996:31-7.
5. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune
interactions. Ann Med. 2003;35:2-11.
6. Bacon L, Stern JS, Keim NL, Van Loan MD. Low bone mass in premenopausal
chronic dieting obese women. Eur J Clin Nutr. 2004;58:966-71.
7. Bandelow B, Krause J, Wedekind D, Broocks A, Hajak G, Ruther E. Early
traumatic life events, parental attitudes, family history, and birth risk factors in patients
with borderline personality disorder and healthy controls. Psychiatry Res. 2005;134:169-
79.
8. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for
mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med.
2004;66:802-13.
9. Belanoff Jea. An Open Label Trial of C-1073 (Mifepristone) for Psychotic
Depression. Biol Psychiatry. 2002;52:386-392.
10. Bellido T, Jilka RL, Boyce BF, et al. Regulation of interleukin-6,
osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J
Clin Invest. 1995;95:2886-95.
11. Bellino S, Zizza M, Rinaldi C, Bogetto F. Combined treatment of major
depression in patients with borderline personality disorder: a comparison with
pharmacotherapy. Can J Psychiatry. 2006;51:453-60.
60